Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cancer breathlessness breakthrough? opioid trial aims to ease suffering

NCT ID NCT04188418

Summary

This study is testing whether fast-acting opioid pain medications (fentanyl or morphine) can help control the distressing shortness of breath that cancer patients often feel during physical activity. About 150 patients will take either one of the opioids or a placebo pill daily for two weeks while performing walking tests to measure their breathing difficulty. The goal is to see if these medications are more effective than a placebo at easing this common and debilitating symptom.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.